Osteosarcoma: Clinical Trials

10 trials for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 4 unknown, 1 completed, 1 terminated. 10 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 110Recruiting 4, Unknown 4, Completed 1, Terminated 1

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Methionine-Reduced Diet - Adenocarcinoma, Basal Cell Carcinoma
Early Phase 1RecruitingUniversity of California, Irvine252026-05-012026-07-31
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
68Ga-B7-H3 Nanobody PET/CT - Osteosarcoma, Osteosarcoma, Recurrent, Refractory
Early Phase 1RecruitingPeking University First Hospital162026-04-012026-08-19
PET-imaging of Two Vartumabs in Patients With Solid Tumors
89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma
Early Phase 1RecruitingVar2 Pharmaceuticals322024-12-102025-12-29
Single Arm Romiplostim to Prevent CIT
Romiplostim (AMG-531) - Ewings Sarcoma, Chemotherapy Induced Thrombocytopenia
Early Phase 1RecruitingChildren's Hospital Medical Center, Cincinnati262024-01-262026-03-18
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Recombinant oncolytic herpes simplex virus type Ⅰ (R130) - Osteosarcoma, Sarcoma
Early Phase 1UnknownShanghai Yunying Medical Technology92023-07-122023-12-14
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Recombinant oncolytic herpes simplex virus type Ⅰ (R130) - Osteosarcoma, Sarcoma
Early Phase 1UnknownShanghai Yunying Medical Technology202023-04-102023-05-09
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
NK510 - Osteosarcoma, Soft Tissue Sarcoma
Early Phase 1UnknownBase Therapeutics (Shanghai) Co., Ltd.122022-09-012023-11-07
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
Targeting CD276 CAR T cells - Osteosarcoma, Neuroblastoma
Early Phase 1UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.242021-05-142021-05-06
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
Glucarpidase, Quality-of-Life Assessment - Osteosarcoma
Early Phase 1CompletedOHSU Knight Cancer Institute112019-03-272026-07-07
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
cyclophosphamide, Cryoablation - Cancer
Early Phase 1TerminatedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins192007-06-012019-01-18

Narrower conditions

Sarcoma (6)  ·  Bone Neoplasms (2)  ·  Breast Neoplasms (2)  ·  Chondrosarcoma (2)  ·  Colonic Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Melanoma (2)  ·  Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Sarcoma, Ewing (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Stomach Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Breast Neoplasms, Male (1)

Broader conditions

Neoplasms by Histologic Type (10)  ·  Neoplasms, Bone Tissue (10)  ·  Neoplasms, Connective Tissue (10)  ·  Neoplasms, Connective and Soft Tissue (10)  ·  Neoplasms (8)  ·  Neoplasms by Site (6)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Neuroectodermal Tumors (4)  ·  Sarcoma (4)  ·  Carcinoma (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Endocrine System Diseases (3)

Interventions

Cryosurgery (1)  ·  Cyclophosphamide (1)  ·  gamma-Glutamyl Hydrolase (1)  ·  glucarpidase (1)  ·  romiplostim (1)

Sponsors

Shanghai Yunying Medical Technology (2)  ·  Base Therapeutics (Shanghai) Co., Ltd. (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  OHSU Knight Cancer Institute (1)  ·  Peking University First Hospital (1)  ·  PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  University of California, Irvine (1)  ·  Var2 Pharmaceuticals (1)

Countries

China (4)  ·  United States (4)  ·  Netherlands (1)

Top investigators

Brian Turpin, DO (1)  ·  Christopher Ryan (1)  ·  Gooitzen van Dam, MD, PhD (1)  ·  Ronald Rodriguez, MD, PhD (1)  ·  Yingqi Hua, phD (1)  ·  Zhaohui A Arter, MD (1)

Results publications

PMID 42094601

NIH funding

P30CA006973 (1)